Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
Citi
Moodys
Teva
US Department of Justice
Merck
Dow
Argus Health
US Army

Generated: April 19, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021108

« Back to Dashboard

NDA 021108 describes RENOVA, which is a drug marketed by Valeant Pharms North and is included in two NDAs. It is available from two suppliers. There is one patent protecting this drug. Additional details are available on the RENOVA profile page.

The generic ingredient in RENOVA is tretinoin. There are twenty-four drug master file entries for this compound. Twenty-five suppliers are listed for this compound. Additional details are available on the tretinoin profile page.
Summary for 021108
Tradename:RENOVA
Applicant:Valeant Pharms North
Ingredient:tretinoin
Patents:1
Therapeutic Class:Antineoplastics
Dermatological Agents
Formulation / Manufacturing:see details
Pharmacology for NDA: 021108
Ingredient-typeRetinoids
Medical Subject Heading (MeSH) Categories for 021108
Suppliers and Packaging for NDA: 021108
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
RENOVA tretinoin CREAM;TOPICAL 021108 NDA Valeant Pharmaceuticals North America LLC 0187-5150 N 0187-5150-02
RENOVA tretinoin CREAM;TOPICAL 021108 NDA Valeant Pharmaceuticals North America LLC 0187-5150 N 0187-5150-60

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:CREAM;TOPICALStrength0.02%
Approval Date:Aug 31, 2000TE:RLD:Yes
Patent:➤ Try a Free TrialPatent Expiration:Mar 7, 2020Product Flag?Substance Flag?Delist Request?

Expired US Patents for NDA 021108

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Valeant Pharms North RENOVA tretinoin CREAM;TOPICAL 021108-001 Aug 31, 2000 ➤ Try a Free Trial ➤ Try a Free Trial
Valeant Pharms North RENOVA tretinoin CREAM;TOPICAL 021108-001 Aug 31, 2000 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Chubb
Harvard Business School
Baxter
UBS
Boehringer Ingelheim
Merck
US Department of Justice
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.